Speaker illustration

Professor Eileen Handberg

University of Florida College of Medicine, Gainesville (United States of America)

Member of:

European Society of Cardiology

Dr. Handberg is a Research Professor of Medicine and Director of the Cardiovascular Clinical Trials Program in the Division of Cardiovascular Medicine and Program Co-Director, OneFlorida Clinical Research Consortium. She also serves the University as an Institutional Review Board member. She is an Adult Nurse Practitioner and has had an outpatient practice, and currently practices on the interventional cardiology inpatient service, and manages research patient care. She is co-I of PCORI funded ADAPTABLE trial. She has contributed to over 120 articles, featured in the Journal of the American College of Cardiology, Journal of the American Medical Association, Circulation, and the Journal of Women’s Health, among others.

Medical management of atrial fibrillation in the presence of heart failure.

Event: ESC Congress 2020

Topic: Advanced Clinical Practice

Session: Atrial Fibrillation and Heart Failure - A Global Challenge for Patient Care


Late sodium channel inhibition (ranolazine) improves angina and myocardial perfusion in patients with severe microvascular coronary dysfunction

Event: ESC Congress 2016

Topic: Microcirculation and collaterals

Session: Microcirculation and inflammation


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb